Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uta Merle

Showing results (131-140 of 188) with videos related to

Pageof 19
Sort By:
Journal of Cancer Research and Clinical Oncology|February 4, 2021
Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunitiesCyrill Wehling, Michael T Dill, Alexander Olkus, et al.
Clinical Genetics|November 16, 2020
Deficiency of acyl-CoA synthetase 5 is associated with a severe and treatable failure to thrive of neonatal onsetKhalid Al-Thihli, Cassian Afting, Nadia Al-Hashmi, et al.
Critical Care Medicine|October 5, 2019
Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory StudyChristian Nusshag, Christoph Rupp, Felix Schmitt, et al.
Journal of Cancer Research and Clinical Oncology|January 25, 2022
Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinomaIsabelle Mohr, Marie Vogeler, Jan Pfeiffenberger, et al.
Hepatology (Baltimore, Md.)|December 19, 2015
Activation of liver X receptor/retinoid X receptor pathway ameliorates liver disease in Atp7B(-/-) (Wilson disease) miceJames P Hamilton, Lahari Koganti, Abigael Muchenditsi, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|November 16, 2024
Absence of cardiac impairment in patients after severe acute respiratory syndrome coronavirus type 2 infection: A long-term follow-up studyJanek Salatzki, Andreas Ochs, Lukas D Weberling, et al.
Viruses|April 30, 2021
From Multiplex Serology to Serolomics-A Novel Approach to the Antibody Response against the SARS-CoV-2 ProteomeJulia Butt, Rajagopal Murugan, Theresa Hippchen, et al.
Orphanet Journal of Rare Diseases|January 22, 2025
A comparative analysis in monitoring 24-hour urinary copper in wilson disease: sampling on or off treatment?Isabelle Mohr, Patrick Lamade, Christophe Weber, et al.
Scientific Reports|March 22, 2022
Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patientsFelix S Seibert, Arturo Blazquez-Navarro, Bodo Hölzer, et al.
Journal of Clinical Medicine|July 29, 2023
Liver-Support Therapies in Critical Illness-A Comparative Analysis of Procedural Characteristics and SafetyDaniel Göth, Christoph F Mahler, Florian Kälble, et al.
Pageof 19

Showing results (131-140 of 188) with videos related to

Sort By:
Pageof 19
Journal of Cancer Research and Clinical Oncology|February 4, 2021
Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunitiesCyrill Wehling, Michael T Dill, Alexander Olkus, et al.
Clinical Genetics|November 16, 2020
Deficiency of acyl-CoA synthetase 5 is associated with a severe and treatable failure to thrive of neonatal onsetKhalid Al-Thihli, Cassian Afting, Nadia Al-Hashmi, et al.
Critical Care Medicine|October 5, 2019
Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory StudyChristian Nusshag, Christoph Rupp, Felix Schmitt, et al.
Journal of Cancer Research and Clinical Oncology|January 25, 2022
Clinical effects and safety of different transarterial chemoembolization methods for bridging and palliative treatments in hepatocellular carcinomaIsabelle Mohr, Marie Vogeler, Jan Pfeiffenberger, et al.
Hepatology (Baltimore, Md.)|December 19, 2015
Activation of liver X receptor/retinoid X receptor pathway ameliorates liver disease in Atp7B(-/-) (Wilson disease) miceJames P Hamilton, Lahari Koganti, Abigael Muchenditsi, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|November 16, 2024
Absence of cardiac impairment in patients after severe acute respiratory syndrome coronavirus type 2 infection: A long-term follow-up studyJanek Salatzki, Andreas Ochs, Lukas D Weberling, et al.
Viruses|April 30, 2021
From Multiplex Serology to Serolomics-A Novel Approach to the Antibody Response against the SARS-CoV-2 ProteomeJulia Butt, Rajagopal Murugan, Theresa Hippchen, et al.
Orphanet Journal of Rare Diseases|January 22, 2025
A comparative analysis in monitoring 24-hour urinary copper in wilson disease: sampling on or off treatment?Isabelle Mohr, Patrick Lamade, Christophe Weber, et al.
Scientific Reports|March 22, 2022
Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patientsFelix S Seibert, Arturo Blazquez-Navarro, Bodo Hölzer, et al.
Journal of Clinical Medicine|July 29, 2023
Liver-Support Therapies in Critical Illness-A Comparative Analysis of Procedural Characteristics and SafetyDaniel Göth, Christoph F Mahler, Florian Kälble, et al.
Pageof 19